Yibigan<sup>®</sup> Insulin Glargine Injection - Sunshine Lake Pharma Co., Ltd.

Home
About Us
R&D Innovation
Internationalization
Pipeline
1. - Anti-infective
2. - Chronic Disease
News & Media
1. - Company News
2. - Media Coverage
Investor
Recruitment

Pipeline

Yibigan<sup>®</sup> Insulin Glargine Injection

Yibigan^® Insulin Glargine Injection

Indications:
Treatment of Type 1 diabetes mellitus and Type 2 diabetes mellitus in adults requiring insulin therapy; and Type 1 diabetes mellitus in adolescents and children aged 6 years and older.

Strength:300 units (pen refill)

National Drug Approval Number:S20210042

Download instruction manual